Trinity College Dublin   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Dublin Ireland (1592)

Organization Overview

First Clinical Trial
2003
NCT00795912
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Adelaide and Meathe Hospital, Incorporating National Children's Hospital | Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital | Dublin Incorporating the National Children's Hospital | School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin, Ireland | St. James's Hospital, Ireland | St Patrick's Hospital, Ireland | St Patrick's Mental Health Services and Trinity College Dublin | St Patrick's University Hospital | St. Patrick's University Hospital | The National Children's Hospital, Tallaght | The University of Dublin, Trinity College | Trinity Colleg Dublin | Trinity College Dublin | Trinity College, Dublin | University Children's Hospital Dublin Irleland | University Clinic Dublin, Dublin, Ireland | University of Dublin | University of Dublin, Trinity College

Active Ingredients

Drugs in Phase 4 Trials (20)

antihemophilic factor viii (Recombinant) (Adynovate) (1 trial)

atazanavir (reyataz) (1 trial)

atorvastatin (lipitor) (1 trial)

coartem (1 trial)

efavirenz (sustiva) (1 trial)

icosapent ethyl (vascepa) (1 trial)

lamivudine (epivir) (1 trial)

levobupivacaine (chirocaine) (1 trial)

lopinavir (Kaletra) (1 trial)

lumefantrine (Coartem) (2 trials)

methohexital sodium (brevital sodium) (1 trial)

nevirapine (viramune) (3 trials)

raltegravir (isentress) (1 trial)

rifampin (1 trial)

ritonavir (Norvir) (2 trials)

sodium chloride (2 trials)

soybean oil (1 trial)

stavudine (zerit) (1 trial)

succinylcholine (anectine) (1 trial)

vitamin d3 (5 trials)

Drugs in Phase 3 Trials (5)

ketamine (ketalar) (5 trials)

midazolam (versed) (5 trials)

nivaldipine (1 trial)

sodium bicarbonate (1 trial)

tauroursodeoxycholic acid (1 trial)

Drugs in Phase 2 Trials (7)

capecitabine (xeloda) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

filgrastim (neupogen) (1 trial)

fludarabine (fludara) (1 trial)

lapatinib (tykerb) (1 trial)

rituximab (rituxan) (1 trial)

sorafenib (nexavar) (1 trial)

Drugs in Phase 1 Trials (3)

aav8-hfix19 (1 trial)

adch3nsmut1 (1 trial)

mva-nsmut (1 trial)

Drugs in Other Trials (26)

bifidobacterium breve (1 trial)

bifidobacterium infantis (1 trial)

bifidobacterium longum (1 trial)

cobalamin (1 trial)

docetaxel (taxotere) (1 trial)

fish oil (Omegavan) (1 trial)

folic acid (1 trial)

Galactose (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (1 trial)

lactobacillus delbrueckii (1 trial)

lactobacillus plantarum (1 trial)

l-epigallocatechin (1 trial)

medium-chain saturated fatty acids (1 trial)

milk protein (1 trial)

octreotide (sandostatin) (2 trials)

prolycopene (1 trial)

sitagliptin (januvia) (1 trial)

somatropin (protropin) (1 trial)

streptococcus salivarius (1 trial)

trastuzumab (herceptin) (1 trial)

ubiquinone (1 trial)

vitamin c (1 trial)

vitamin e (1 trial)

vsl #3 (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Alzheimer Disease (Phase 3)

Amyotrophic Lateral Sclerosis (Phase 3)

Bipolar Disorder (Phase 1)

Crohn Disease (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 1)

Disease (Phase 1)

Esophageal Neoplasms (Phase 4)

Heart Failure (Phase 4)

Hemophilia A (Phase 4)

Hemophilia B (Phase 1)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

HIV Infections (Phase 4)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Motor Neuron Disease (Phase 3)

Multiple Sclerosis (Phase 2)

Muscle Weakness (Phase 4)

Pancreatic Neoplasms (Phase 2)

Paresis (Phase 4)

Recurrence (Phase 1)

Sclerosis (Phase 3)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 2)

Tuberculosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 43
  • # of Trial APIs: 61